RecruitingNCT07567131
Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)
Studying Congenital erythropoietic porphyria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Portal Therapeutics, Inc.
- Enrollment
- 50 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2026 – 2027
Study locations (19)
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Mount Sinai School of Medicine, New York, New York, United States
- Wake Forest University Baptist Health - Dept of Gastroenterology, Wake Forest, North Carolina, United States
- Temple University, Philadelphia, Pennsylvania, United States
- University of Texas Health - Ertan Digestive Disease Center, Houston, Texas, United States
- UZ Leuven, Leuven, Belgium
- University of Alberta Hospital, Edmonton, Canada
- Centre Hospitalier Universitaire de Bordeaux - Hopital Saint - Andre, Bordeaux, France
- AP-HP Hopital Bichat - Claude Bernard, Paris, France
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy
- Azienda Ospedaliero-Universitaria di Modena, Modena, Italy
- Haukeland University Hospital, Bergen, Norway
- Hospital Universitario 12 de Octubre, Madrid, Spain
- Consorcio Hospital General Universitario de Valencia, Valencia, Spain
- Gazi University Faculty of Medicine, Ankara, Turkey (Türkiye)
- +4 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07567131 on ClinicalTrials.govOther trials for Congenital erythropoietic porphyria
Additional recruiting or active studies for the same condition.